BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 30, 2005
View Archived Issues
Good results obtained with a meningococcal/pneumococcal vaccine in infants
Read More
Extended use of the contraceptive NuvaRing reported safe and effective
Read More
New data on the benefits of lasofoxifene in vaginal atrophy
Read More
Update on the effects of lanthanum carbonate in dialysis patients
Read More
Blocking cathepsins alleviates experimental colitis / News in Context
Read More
Dermatological application for NeoPharm's new compound K6PC-5
Read More
New approaches to influenza vaccine
Read More
Nabi Biopharmaceuticals begins early clinical development of S. epidermidis vaccine
Read More
SCLOR Pharma evaluates bioavailability of CDT-raloxifene
Read More
Ziopharm initiates early clinical development of ZIO-101
Read More
Acologix expands AC-100 phase II development for periodontal bone loss
Read More
IMI to change name to PreMD
Read More
Chromos to acquire Targeted Molecules
Read More
Alfimeprase phase III program for CO indication poised for initiation
Read More
Patient enrollment continues in world's largest drug-eluting stent registry
Read More
Preliminary efficacy data does not support further clinical development of palosuran
Read More
Philinopside A exerts antiangiogenic and cytotoxic effects in vitro and in vivo
Read More
Cardioprotective properties of ARD-353 described in a preclinical model
Read More
Synthetic derivative of rocaglaol effective in preclinical models of neurodegenerative diseases
Read More
Focalin XR approved for ADHD
Read More
Cylene completes financing to advance CX-3543 into the clinic
Read More
New Invirase 500 mg formulation approved in Europe
Read More
Hylenex NDA accepted for review
Read More
CytoGenix licenses DNA plasmid from NIH
Read More
Merrem approved for complicated skin and skin structure infections
Read More
First phase I study of OT-551 for cataracts meets all safety and comfort endpoints
Read More
Antisense technology provides therapeutic target in lymphoproliferative disorders
Read More
Recent patents report new treatments for psychotic disorders
Read More
Novel antiinflammatory agents claimed in patent literature
Read More
Epithelial sodium channel blockers discovered at Parion
Read More